Home » KAI PHARMACEUTICALS, INC. AND SANKYO COMPANY, LIMITED ENTER GLOBAL ALLIANCE
KAI PHARMACEUTICALS, INC. AND SANKYO COMPANY, LIMITED ENTER GLOBAL ALLIANCE
KAI Pharmaceuticals, Inc., a privately held biotechnology company, and DAIICHI SANKYO COMPANY, LIMITED today announced that Sankyo Company, Limited, a wholly owned subsidiary of DAIICHI SANKYO, and KAI Pharmaceuticals have entered an agreement for the global development and commercialization of KAI-9803, with an initial focus on cardiovascular disease.
PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/01-09-2006/0004245083&EDATE=)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May